Sotera Health Co Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
11.3%projected annual EPS growth
Analyst Coverage
9analysts covering
FY Revenue (est.)
$1.2Bnext fiscal year
FY EPS (est.)
$0.98next fiscal year
Monitoring Framework
Key Performance Indicators
Net Revenues Quarterly1.2BTarget: 5.0% to 6.5% growth
Adjusted EBITDA Quarterly594MTarget: $632 million to $641 million
Net Leverage Ratio Quarterly3.2x
Watch Items
- Ethylene Oxide (EO) Litigation and Regulatory ComplianceTrigger: Adverse rulings in remaining ~450 Georgia cases or stricter EPA NESHAP standardsAction: Monitor legal defense outcomes, settlement reserves, and capital expenditures for state-of-the-art emission control systems.
- CEO Transition ExecutionTrigger: Alton Shader's assumption of the CEO role effective May 26, 2026Action: Assess strategic continuity, commercial execution, and integration of new leadership under Executive Chairman Michael B. Petras, Jr.
Research as of 19 Jun 2026